By U.S. Sen. Maggie Hassan

Bad actors in the pharmaceutical industry are engaging in unconscionable practices — including annual price spikes on existing drugs and efforts to decrease competition — that hurt patients and public health and bankrupt families. Yet, for far too long, Congress has done nothing, refusing to even require the basic transparency necessary to shed light on companies’ deceptive practices.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.